World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Immunology
USA
2026

D-Index & Metrics

Best Scientists

D-Index
189
Citations
124453
World Ranking
445
National Ranking
296

Immunology

D-Index
191
Citations
127828
World Ranking
21
National Ranking
15

Medicine

D-Index
192
Citations
128623
World Ranking
244
National Ranking
164

Charles N. Serhan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Charles N. Serhan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 744 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Charles N. Serhan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Charles N. Serhan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 191 D-Index — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Immunology in United States Leader Award
  • 2010 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Charles N. Serhan is affiliated with Brigham and Women's Hospital in the United States. Their research primarily focuses on medicine and biochemistry, genetics, and molecular biology, with significant contributions in nutrition and dietetics, immunology, biochemistry, molecular biology, and pharmacology.

Their work encompasses various scientific topics, including:

  • Fatty Acid Research and Health
  • Eicosanoids and Hypertension Pharmacology
  • Immune Response and Inflammation
  • S100 Proteins and Annexins
  • Inflammatory mediators and NSAID effects
  • Advanced Glycation End Products research
  • Immune cells in cancer

Serhan has frequently published in several scientific venues, such as:

  • The FASEB Journal
  • IUPHAR/BPS Guide to Pharmacology CITE
  • Proceedings of the National Academy of Sciences
  • Cancer Research
  • Cancer and Metastasis Reviews

Coauthor collaborations include multiple publications with:

  • Robert Nshimiyimana
  • Nan Chiang
  • Dipak Panigrahy
  • Bruce D. Levy
  • Darlene A. Dartt

Representative recent papers authored or coauthored by Serhan include:

  • "Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions," 2022, Progress in Lipid Research
  • "Specialized pro-resolving mediator network: an update on production and actions," 2020, Essays in Biochemistry
  • "Resolution of inflammation: An organizing principle in biology and medicine," 2021, Pharmacology & Therapeutics
  • "Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?," 2020, Cancer and Metastasis Reviews
  • "Carcinogenesis: Failure of resolution of inflammation?," 2020, Pharmacology & Therapeutics

Charles N. Serhan has been recognized as a Fellow of the American Association for the Advancement of Science (AAAS) in 2010.

Best Publications

  • Resolving inflammation : dual anti-inflammatory and pro-resolution lipid mediators

    Charles N. Serhan;Nan Chiang;Thomas E. Van Dyke

  • Pro-resolving lipid mediators are leads for resolution physiology

    Charles N. Serhan

  • Resolution of inflammation: the beginning programs the end.

    Charles N Serhan;John Savill

  • Leukotrienes and lipoxins: structures, biosynthesis, and biological effects

    Bengt Samuelsson;Sven-Erik Dahlén;Jan Åke Lindgren;Carol A. Rouzer

  • Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.

    Charles N. Serhan;Song Hong;Karsten Gronert;Sean P. Colgan

  • Lipid mediator class switching during acute inflammation: signals in resolution

    Bruce D. Levy;Clary B. Clish;Birgitta Schmidt;Karsten Gronert

  • Novel Functional Sets of Lipid-Derived Mediators with Antiinflammatory Actions Generated from Omega-3 Fatty Acids via Cyclooxygenase 2–Nonsteroidal Antiinflammatory Drugs and Transcellular Processing

    Charles N. Serhan;Clary B. Clish;Jessica Brannon;Sean P. Colgan

  • Resolvin E1 and protectin D1 activate inflammation-resolution programmes.

    Jan M. Schwab;Nan Chiang;Makoto Arita;Makoto Arita;Charles N. Serhan

  • Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators.

    Charles N. Serhan;Bruce D. Levy

  • Resolution of inflammation: state of the art, definitions and terms.

    Charles N. Serhan;Sue D. Brain;Christopher D. Buckley;Derek W. Gilroy

  • TLR11 Activation of Dendritic Cells by a Protozoan Profilin-Like Protein

    Felix Yarovinsky;Dekai Zhang;John F. Andersen;Gerard L. Bannenberg

  • Resolution Phase of Inflammation: Novel Endogenous Anti-Inflammatory and Proresolving Lipid Mediators and Pathways

    Charles N. Serhan

  • Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells: AUTACOIDS IN ANTI-INFLAMMATION *

    Song Hong;Karsten Gronert;Pallavi R. Devchand;Rose-Laure Moussignac

  • Resolvins and Protectins in Inflammation-Resolution

    Charles N. Serhan;Nicos A. Petasis

  • Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1

    Makoto Arita;Francesca Bianchini;Julio Aliberti;Alan Sher

  • A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease.

    Walter J. Lukiw;Jian Guo Cui;Victor L. Marcheselli;Merete Bodker

  • Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions

    Charles N. Serhan;Rong Yang;Kimberly Martinod;Kie Kasuga

  • Lipoxins: novel series of biologically active compounds formed from arachidonic acid in human leukocytes

    Charles N. Serhan;Mats Hamberg;Bengt Samuelsson

  • Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene Expression

    Victor L. Marcheselli;Song Hong;Walter J. Lukiw;Xiao Hua Tian

  • Neuroprotectin D1: A docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress

    Pranab K. Mukherjee;Victor L. Marcheselli;Charles N. Serhan;Nicolas G. Bazan

Frequent Co-Authors

Nan Chiang
Nan Chiang Brigham and Women's Hospital
Jesmond Dalli
Jesmond Dalli Queen Mary University of London
Nicos A. Petasis
Nicos A. Petasis University of Southern California
Bruce D. Levy
Bruce D. Levy Brigham and Women's Hospital
Romain A. Colas
Romain A. Colas Brigham and Women's Hospital
Clary B. Clish
Clary B. Clish Broad Institute
Karsten Gronert
Karsten Gronert University of California, Berkeley
Sean P. Colgan
Sean P. Colgan University of Colorado Anschutz Medical Campus
Bengt Samuelsson
Bengt Samuelsson Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding your knowledge through related advanced nursing degrees can open diverse career opportunities. Many students explore psychiatric and mental health specialties, and finding the best pmhnp programs online is crucial for ensuring strong clinical placements and practical experience.

Cost is another important factor. The availability of the cheapest psychiatric nurse practitioner programs enables more students to pursue their goals without excessive financial burdens. Balancing affordability with program quality is key to a successful educational journey.

Understanding the financial outlook is equally vital. Resources offering dnp salary transparency help prospective students gauge potential earnings across different states, which can influence career decisions and geographic preferences.

For those already in nursing, advancing credentials such as acute care nurse practitioner certification can allow transitions into more specialized, high-demand roles. This pathway offers an opportunity to leverage existing skills while addressing critical healthcare needs.

Exploring these related degrees and career pathways can enrich your expertise in Immunology and healthcare, enhancing both your skills and job prospects.

Learn more about the best pmhnp programs online, the cheapest psychiatric nurse practitioner programs, dnp salary transparency, and how to achieve acute care nurse practitioner certification.

Best Scientists Citing Charles N. Serhan

Trending Scientists

Recently Published Articles